Hyperbranched poly(β-amino ester)s-mediated delivery of engineered Klotho mRNA rescues senescence and restores cellular homeostasis in aged and Klotho deficient iMSCs.

A decline in Klotho expression is a defining feature of aging and contributes to cellular dysfunctions. Here, we developed an engineered IVT Klotho mRNA incorporating ARCA capping. Ψ-modification and poly(A) tailing, delivered using a hyperbranched …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Intermittent Fasting Attenuates Cognitive Decline in D-Galactose-Induced Aging Rats in Association with β-Hydroxybutyrate and PI3K/AKT/GSK-3β Signaling.

Age-related cognitive decline is a major public health concern, with few effective interventions available. Intermittent fasting (IF) has emerged as a promising metabolic intervention, potentially enhancing neuroprotection through increased β-hydroxybutyrate (BHB) production. This study aimed …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Gene activity patterns reveal how some people stay healthy longer

Researchers analyzed blood gene activity in nearly 2,500 people from long-lived families and found specific genetic signatures associated with aging and survival—including immune system strength and inflammation control. A machine learning model trained on these …

56 Promising
Design 11
Sample 13
Peer Review 15
Replication 7
Transparency 10

Genetic background influences MAFAS64F-mediated diabetes penetrance in male mice

Pancreatic beta-cells require the coordinated expression of transcription factors such as MAFA to dynamically secrete insulin to maintain euglycemia. A naturally occurring mutation in MAFA (MAFAS64F) produces a long-lived variant protein which predisposes carriers to …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

Skin as a sentinel and modulator of systemic aging: a translational framework for evidence-based gerotherapeutics.

Aging is increasingly recognized as a dynamic and potentially modifiable biological process, yet translation of mechanistic discoveries into clinically validated interventions that extend human healthspan remains limited. Because dermatologists can directly observe, sample, and quantify …

44 Early
Design 5
Sample 7
Peer Review 16
Replication 6
Transparency 10

Ribonuclease DIS3 delays aging and senescence by generating tRNA halves.

Transfer RNA (tRNA) halves (tRHs) are generated via the cleavage of tRNAs, but their roles in aging and longevity remain poorly understood. Here, we demonstrate a direct role of tRHs in aging in metazoans. Through …

47 Early
Design 5
Sample 7
Peer Review 19
Replication 6
Transparency 10

Both genome instability and replicative senescence stem from the shortest telomere in telomerase-negative cells.

In the absence of telomerase, telomere shortening triggers replicative senescence, a tumor suppressor mechanism that is also associated with oncogenic genomic instability. Yet, the precise mechanism that connects these seemingly opposing forces remains poorly understood. …

47 Early
Design 5
Sample 7
Peer Review 19
Replication 6
Transparency 10

Microglial senescence and epigenetic reprogramming in alzheimer's disease: An immunometabolic perspective.

Microglial senescence has emerged as a potentially important aging-related mechanism in Alzheimer's disease (AD), shaped in part by epigenetic reprogramming and closely coupled to immunometabolic dysfunction. While microglia initially mount adaptive responses to amyloid-beta (Aβ), …

44 Early
Design 5
Sample 7
Peer Review 16
Replication 6
Transparency 10

Replicative senescence of neural progenitors induces astrocyte senescence in 2D cultures and human midbrain organoids

Astrocyte senescence (astrosenescence) has emerged as a potential mechanism through which ageing may progressively impair glial homeostatic neuronal support and render the brain more vulnerable to neurodegenerative diseases such as Parkinsons disease (PD). Yet human …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

Can senolytic drugs restore fertility in female mice with fatty liver disease?

Researchers treated female mice with fatty liver disease (MASLD) using senolytic drugs—compounds that eliminate senescent (aged) cells—and found pregnancy rates improved, particularly through reduced aging and inflammation in the ovaries. However, the treatment had limited …

39 Early
Design 6
Sample 6
Peer Review 13
Replication 5
Transparency 9

Rejuvenation Potential of Developmental Genes Downregulated in Aging.

Partial reprogramming with Yamanaka factors effectively reverses cellular aging but poses potential oncogenic risks, limiting clinical translation. To identify safer rejuvenation induction factors (RIFs), we integrated five aging datasets and compared them with single-cell transcriptomics …

46 Early
Design 5
Sample 7
Peer Review 18
Replication 6
Transparency 10

Multi-omics profiling reveals systemic rejuvenation of the aged kidney through senolytic therapy.

Cellular senescence is a key driver of kidney aging, leading to functional decline and increased susceptibility to chronic kidney disease. While the senolytic combination of dasatinib and quercetin (D + Q) has shown promise in …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

How immune cells called NK cells shape healthy aging

This review synthesizes evidence that natural killer (NK) cells—a type of immune cell—undergo age-related changes that impair their ability to clear damaged cells and regulate inflammation, contributing to aging-related diseases. The authors propose NK cell …

35 Early
Design 4
Sample 2
Peer Review 11
Replication 9
Transparency 9

Immunosenescence in Human Disease: Mechanistic Insights and Therapeutic Opportunities.

Immunosenescence, an age-associated decline in immune function, is increasingly recognized as a central determinant of health and disease in older adults. Characterized by thymic involution, loss of naïve T cells, contraction of T cell receptor …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Eugenol from Syzygium aromaticum enhances longevity and proteostasis in aged yeast.

Clove (Syzygium aromaticum) extracts promote longevity in several model systems, yet the underlying molecular mechanisms responsible for the pro-longevity remain poorly defined. This study utilized a Saccharomyces cerevisiae model to investigate how clove extracts modulate …

44 Early
Design 5
Sample 7
Peer Review 16
Replication 6
Transparency 10

Keeping Cells Fit in Old Age by Rewiring a Key Metabolic Switch

Researchers found a way to keep old cells working well by tweaking one metabolic switch, suggesting aging loss of fitness isn't inevitable.

Researchers found that activating a protein called AMPK can prevent aging-related fitness decline in yeast cells, but only if you also prevent it from shutting down fat production—a dual problem that a specially engineered AMPK …

30 Early
Design 6
Sample 7
Peer Review 3
Replication 5
Transparency 9

How aging immune systems damage lungs—and what treatments might help

If your immune system ages slower, your lungs might stay healthier longer—but we need better treatments to prove it works.

This review examines how immunosenescence (age-related immune decline) drives lung diseases like COPD, fibrosis, and cancer, and surveys emerging treatments including senolytics, stem cell therapy, and lifestyle interventions. While it synthesizes current knowledge well, it's …

36 Early
Design 4
Sample 2
Peer Review 13
Replication 7
Transparency 10

Emergence of heartbeat frailty in advanced age II: individual cardiovascular aging trajectories revealed by lifelong echocardiography in male mice.

Chronological age is the strongest risk factor for cardiovascular disease, yet individual trajectories of cardiovascular aging, particularly during late life, remain incompletely characterized. We performed quarterly echocardiography in 58 male C57BL/6 mice from 6 months …

44 Early
Design 5
Sample 7
Peer Review 16
Replication 6
Transparency 10

Popular Senolytic Drugs Failed to Work in Rigorous Independent Testing

Drugs once thought to slow aging didn't work in independent tests—be cautious about anti-aging claims until proven by multiple labs.

Researchers from multiple labs independently tested two widely-publicized senolytic drugs (a GLS1 inhibitor and anti-PD-1 antibody) and found they did not reduce senescent cells or improve aging in mice—contradicting earlier claims. This highlights a serious …

60 Promising
Design 11
Sample 10
Peer Review 15
Replication 13
Transparency 11

Rethinking senescent cells: When to stop them, when to keep them

Some aging cells help your body work properly; new strategies could clear harmful ones while keeping helpful ones.

This review challenges the assumption that senescent cells are always harmful, showing that some actually support healthy aging through wound healing and tissue maintenance. The authors propose a new strategy: prevent bad senescence while selectively …

37 Early
Design 4
Sample 2
Peer Review 13
Replication 9
Transparency 9